Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALBO | AVBP | NUVB | ||
| Company | Albireo Pharma Inc | Arrivent Biopharma Inc | Nuvation Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 44.90 | 27.56 | 2.57 | ||
| High | 44.90 | 27.81 | 2.74 | ||
| Low | 43.99 | 26.53 | 2.55 | ||
| Last | 44.15 | 26.59 | 2.70 | ||
| Change | -0.10 | -0.82 | +0.12 | ||
| % Change | -0.23% | -2.99% | +4.65% | ||
| Volume | 1,241,200 | 187,100 | 4,547,900 | ||
| 20-Day Average Volume | 635,260 | 148,665 | 2,414,450 | ||
| Previous Close | 44.25 | 27.41 | 2.58 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 44.18 | 30.89 | 2.56 | ||
| 20-Day Raw Stochastic | 43.90% | 1.91% | 57.78% | ||
| 20-Day Relative Strength | 72.09% | 42.73% | 53.18% | ||
| Weighted Alpha | +16.30 | +37.36 | +17.85 | ||
| Today's Opinion | 88% Buy | 56% Buy | 24% Sell | ||
| Previous Opinion | 100% Buy | 56% Buy | 24% Sell | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.28% since 02/23/23 | -5.31% since 11/14/24 | -5.92% since 11/14/24 | ||
| Low | 43.53 on 02/24/23 | 26.40 on 11/19/24 | 2.43 on 11/19/24 | ||
| High | 44.90 on 03/02/23 | 28.82 on 11/20/24 | 2.90 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -0.90% since 02/02/23 | -7.38% since 10/21/24 | +14.41% since 10/21/24 | ||
| Low | 43.31 on 02/23/23 | 26.40 on 11/19/24 | 2.18 on 11/05/24 | ||
| High | 45.23 on 02/03/23 | 36.37 on 11/08/24 | 3.08 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +85.66% since 12/02/22 | +11.16% since 08/21/24 | -3.57% since 08/21/24 | ||
| Low | 17.78 on 12/27/22 | 22.30 on 09/13/24 | 2.00 on 10/10/24 | ||
| High | 45.23 on 02/03/23 | 36.37 on 11/08/24 | 3.40 on 08/29/24 | ||
| 6-Month | |||||
| %Chg | +156.84% since 09/02/22 | +33.28% since 05/21/24 | -20.59% since 05/21/24 | ||
| Low | 16.02 on 09/07/22 | 15.53 on 06/20/24 | 2.00 on 10/10/24 | ||
| High | 45.23 on 02/03/23 | 36.37 on 11/08/24 | 3.97 on 07/31/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 913,949 | 923,635 | 868,343 | ||
| Shares Outstanding, K | 20,701 | 33,697 | 336,567 | ||
| Annual Sales | 40,580,000 | 0 | 0 | ||
| Annual Net Income | -34,030,000 | -69,330,000 | -75,800,000 | ||
| Last Quarter Sales | 9,830,000 | 0 | 730,000 | ||
| Last Quarter Net Income | -37,800,000 | -20,560,000 | -41,210,000 | ||
| 60-Month Beta | 1.03 | N/A | 1.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.89 on 11/08/22 | -0.61 on 11/14/24 | -0.15 on 11/06/24 | ||
| Latest Earnings Date | 03/07/23 | 11/13/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||